Tag Archives: ovalbumin

Sharing the Steel: What The Every Company and ADM Are Quietly Teaching Us About Scale-Up

By | July 29, 2026

The Every Company’s decision to manufacture its recombinant egg white protein OvoPro at ADM’s Clinton, Iowa facility, alongside existing capacity at Huvepharma’s Bulgarian subsidiary Biovet, illustrates a shift in how precision fermentation companies approach commercial scale-up. Rather than building proprietary plants, co-manufacturing allows capital to remain available for strain engineering and product development. The approach… Read More: Sharing the Steel: What The Every Company and ADM Are… »

The Ovalbumin Patent Fight and What It Tells Us About Where Precision Fermentation Is Going

By | May 22, 2026

The Every Company and Onego Bio are now fighting over recombinant ovalbumin in courts on two continents. The way this case resolves will shape how broadly IP rights can be enforced in precision fermentation, and what that means for the rest of us building this industry.